# GLyPharma Therapeutic

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/glypharma-therapeutic

- Industry: Pharmaceuticals
- Headquarters: Montreal, Canada
- Website: www.glypharma.com
- Total disclosed funding: $12M
- Latest round: Series A (Sep 1, 2012)
- Investors on record: 1

## About

GLyPharma Therapeutic Inc. is a pharmaceutical company focused on developing innovative therapies aimed at transforming patient care and improving health outcomes within the healthcare sector.GLyPharma Therapeutic Inc. was founded in 2012 and is headquartered in Montreal, Canada. The company specializes in pharmaceutical development. The most recent significant transaction occurred in October 2018 when Therachon AG, part of a larger investment consortium, acquired GLyPharma Therapeutic Inc. Financial terms of the acquisition were not disclosed. The company has completed 2 deals to date, with the most recent deal date being in October 2018. The latest funding round was a Series A round, raising CAD 12.000 mn, which is also the total amount raised by the company. CTI Life Sciences participated as an investor in this round.Glypharma.com is a domain name for sale, primarily marketed to businesses and individuals seeking to establish an online presence in the pharmaceutical sector. The core offering is the domain name itself, serving as a unique digital address for e-commerce platforms, informational websites, and pharmaceutical service providers. The aim is to support branding and customer recognition in a competitive market. Potential customers include pharmaceutical companies, healthcare startups, and organizations focusing on health-related products and services, targeting markets in the United States, Europe, and other regions with a growing interest in health and wellness solutions.Revenue generation for Glypharma.com is derived from the sale of the domain name, priced at CAD 6,495, with an option for potential buyers to utilize a payment plan of CAD 270.63 per month over 24 months. The structure is primarily direct-to-consumer, facilitating purchases through the company's platform. The revenue model may include additional offerings such as WhoIs Privacy Protection, provided free for the first year and incurring a fee in subsequent years, positioning the domain name as a flagship product for businesses seeking to enhance their online visibility in the pharmaceutical industry.GLyPharma Therapeutic Inc. is strategizing future growth by focusing on the launch of new products and services related to pharmaceutical development. While specific release dates have not been disclosed, the company intends to expand its market presence further into the United States and Europe. The recent Series A funding of CAD 12.000 mn is expected to support these initiatives, allowing for enhancements in product development and market expansion efforts. The acquisition by Therachon AG may also present new opportunities for collaborative growth in the pharmaceutical field.

## Funding rounds

- Series A, Sep 1, 2012, $12M — CTI Life Sciences

## Investors

- CTI Life Sciences (https://capitalatlas.ai/funds/cti-life-sciences) — Series A